Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00585949 · ClinicalTrials.gov registry record

Age and Endothelial Progenitor Cell Mobilization

A clinical trial of Coronary Artery Disease, sponsored by Emory University.

Completed
Registry status
123
Enrollment target
2
Study locations

NCT00585949: Completed study of Coronary Artery Disease, sponsored by Emory University.

NCT00585949 is a study of Coronary Artery Disease that has completed, run by Emory University. The registered enrollment target is 123 participants, below the 1,286-participant average among 219 other Coronary Artery Disease trials with a reported enrollment target (90% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00585949, a study of Coronary Artery Disease, has completed, sponsored by Emory University.

COMPLETED
Registry status
123 participants
Enrollment target
2
Study locations

Study Summary

It is hypothesized that aging is associated with reduced vascular injury-induced endothelial progenitor cell activity, resulting in impaired vascular repair and increased vascular disease. Patients with stable coronary artery disease will be enrolled in this observational study and will undergo either angiography alone or angiography and angioplasty. Participants will be followed for 5 years.

Primary Outcome

Activity of endothelial progenitor cells will be assessed in participants following their procedures.

Conditions Studied

Interventions

  • PROCEDURE Angiography
  • PROCEDURE Percutaneous Coronary Angioplasty

Study Locations (2)

Georgia

  • Atlanta VA Medical Center - Atlanta
  • Emory University Hospital - Atlanta

Trial Details

FieldValue
Enrollment Target 123 participants
Start Date 2006-07
Est. Completion 2008-10-09
Emory University

1,208 total trials

What the finished NCT00585949 record still lists

NCT00585949 is an observational study that tracks outcomes without assigning an intervention. The registered 123 participants enrollment target is mid-sized for trials with a published cap, below the 1,286-participant average among 219 other Coronary Artery Disease trials with a reported enrollment target (90% lower).

The record links to 1 condition, with Coronary Artery Disease appearing as the primary indexed condition, and to 2 interventions - of which Angiography is the first listed.

NCT00585949 reports a single indexed study location in Georgia.

Frequently Asked Questions

What is clinical trial NCT00585949 about?

NCT00585949 is a clinical study titled "Age and Endothelial Progenitor Cell Mobilization". It is hypothesized that aging is associated with reduced vascular injury-induced endothelial progenitor cell activity, resulting in impaired vascular repair and increased vascular disease. Patients with stable coronary artery disease will be enrolled in this observational study and will undergo eith...

What is the current status of trial NCT00585949?

This trial is currently completed. The enrollment target is 123 participants. The study started on 2006-07. Estimated completion is 2008-10-09.

What conditions does trial NCT00585949 study?

This clinical trial studies the following conditions: Coronary Artery Disease.

What interventions are being tested in trial NCT00585949?

The interventions under investigation include: Angiography (PROCEDURE), Percutaneous Coronary Angioplasty (PROCEDURE).

Who is sponsoring clinical trial NCT00585949?

This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00585949 being conducted?

This trial has 2 study locations across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Coronary Artery Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00585949's enrollment target sits among peer trials

123 136th of 219 higher than 84 of 219 other Coronary Artery Disease trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Coronary Artery Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05285891 · 123 participants · Phase 4

    Ocrelizumab Discontinuation in Relapsing Multiple Sclerosis

  • NCT05334368 · 123 participants · Phase 3

    Depemokimab in Participants With Hypereosinophilic Syndrome, Efficacy, and Safety Trial

  • NCT06088355 · 123 participants · NA

    Moderate Versus High Volume Light-Moderate Intensity Exercise for People With Moderate Parkinson's Disease

  • NCT06111131 · 123 participants · NA

    Ancora-SB Overtube Complete Positioning and Optical Visualization During Endoscopic Procedures

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00585949, the US trial registry maintained by the National Library of Medicine. NCT00585949 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.